Tengonermin

Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment.
Read more
€0.00 (tax incl.)
Reference:
HY-P99565
Product Details
HY-P99565

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
Cancer-programmed cell death
CAS
1960461-99-7

Menu

Settings